Epigenomics Epigenomics H1 Revenues Down 31 Percent The company attributed the revenue decline to the SARS-CoV-2 pandemic, which has caused patients eligible for its colon cancer test to delay screenings. Epigenomics Reports 24 Percent Drop in 2020 Revenues, Seeks Sale After Negative Coverage Decision The firm said that due to a negative coverage decision and capital constraints, it is evaluating options including a sale by a public takeover or an asset deal. CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon The final decision includes some changes, most notably removing requirements for guideline inclusion, but retains its technical performance benchmarks. Epigenomics Issues €5.5M Convertible Bond The proceeds of the bond are going to support the firm's operations as it awaits a final Medicare coverage decision on its colon cancer test. Epigenomics Posts 30 Percent Rise in Q3 Revenues A negative preliminary decision regarding reimbursement for the company's flagship colon cancer screening test in the US remains an issue for the company. Aug 13, 2020 Epigenomics Q2 Revenues Slide 76 Percent on Coronavirus Challenges May 7, 2020 Epigenomics Q1 Revenues Down 28 Percent Apr 29, 2020 Epigenomics Preliminary Q1 Revenues Drop 33 Percent Feb 29, 2020 CMS Seeks Public Input on Epigenomics' National Coverage Request for Colon Cancer Screening Test Nov 19, 2019 Epigenomics Posts 69 Percent Drop in Q3 Revenues Aug 7, 2019 Epigenomics Q2 Revenues Slide 25 Percent May 10, 2019 Guardant Health Announces Plans for Prospective Colorectal Cancer Screening Study Premium May 8, 2019 Epigenomics Q1 Revenues Rise 7 Percent Mar 27, 2019 Epigenomics 2018 Revenues Down 21 Percent Mar 13, 2019 BioChain Threatens Legal Action Against Epigenomics for Contract Termination Mar 6, 2019 Epigenomics Terminates BioChain Licensing Deal; Provides 2019 Revenue Outlook Dec 27, 2018 Epigenomics Pushes New Promotion Efforts for ProColon Test as Other Assays in Pipeline Advance Premium Dec 21, 2018 In Brief This Week: QuantuMDx, Molbio, Seegene, Qiagen, Epigenomics, More Nov 7, 2018 Epigenomics Posts 57 Percent Rise in Q3 Revenues Aug 8, 2018 Epigenomics Posts 88 Percent Increase in Q2 Revenues May 9, 2018 Epigenomics Posts 10 Percent Q1 Revenue Increase Mar 23, 2018 Epigenomics 2017 Revenues Down 55 Percent Dec 19, 2017 Epigenomics Lung Cancer Test Receives CE-IVD Mark Sep 21, 2017 Epigenomics Initiates €5.5M Private Placement Aug 9, 2017 Epigenomics Reports 81 Percent Drop in Q2 Revenues; Takeover Bid Fails Load More Breaking News SUPER Psychosis Study Presented at ASHG Digs Into Relationships of Rare Variants, Phenotypes People in the News: New Appointments at Myriad Genetics, Becton Dickinson, Delfi Diagnostics, More In Brief This Week: Virginia Commonwealth University, Dovetail Genomics, Lucid Diagnostics, and More New Products Posted to GenomeWeb: Bio-Rad, PerkinElmer, Ares Genetics, Purigen Biosystems, More Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China MultiMuTHER Team Tracks Expression, Metabolite Relationships in Aging TwinsUK Participants The Scan More Boosters for US Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes. From a Pig A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports. For Privacy's Sake Wired reports that more US states are passing genetic privacy laws. Science Paper on How Poaching Drove Evolution in African Elephants In Science this week: poaching has led to the rapid evolution of tuskless African elephants.